Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites

Archives of Virology

Volumn 141, Issue 3-4, 1996, Pages 587-600

  Kirkwood, C D ^a   Bishop, R F ^a   Coulson, B S ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN; VP4 PROTEIN, ROTAVIRUS; VP7 PROTEIN, ROTAVIRUS;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CROSS REACTION; EPITOPE MAPPING; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ROTAVIRUS; SERODIAGNOSIS; SEROTYPING; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS CAPSID;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; CAPSID; CAPSID PROTEINS; CELL LINE; CROSS REACTIONS; EPITOPE MAPPING; HUMANS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; ROTAVIRUS; SEROTYPING; VARIATION (GENETICS);

EID: 0029689241     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01718319     Document Type: Article

References (28)

1. Bishop RF (1995) Natural history of human rotavirus infections. In: Kapikian AZ (ed) Viral infections of the gastrointestinal tract, 2nd ed. Marcel Dekker, New York, pp 131-167
2. Chen D, Estes MK, Ramig RF (1992) Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J Virol 66: 432-439
3. Coulson BS (1993) Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies. J Clin Microbiol 31: 1-8
4. Coulson BS, Fowler KJ, Bishop RF, Cotton RGH (1985) Neutralizing monoclonal antobodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol 54: 14-20
5. Coulson BS, Kirkwood C (1991) Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J Virol 65: 5968-5974
6. Coulson BS, Tursi JM, McAdam WJ, Bishop RF (1986) Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology 154: 301-312
7. Dyall-Smith ML, Holmes IH (1984) Sequence homology between human and animal rotavirus serotype-specific glycoproteins. Nucleic Acids Res 12: 3973-3982
8. Estes MK, Cohen J (1989) Rotavirus genome structure and function. Microbiol Rev 53: 410-449
9. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30: 1365-1373
10. Gorziglia M, Green K, Nishikawa K, Taniguchi K, Jones R, Kapikian AZ, Chanock RM (1988) Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol 62: 2978-2984
11. Gorziglia M, Larralde G, Kapikian AZ, Chanoch RM (1990) Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci USA 87: 7155-7159
12. Hoshino Y, Wyatt RG, Flores J, Midthun K, Kapikian AZ (1985) Serotypic characterization of rotavirus derived from asymptomatic human neonatal infections. J Clin Microbiol 21: 425-430
13. Isegawa Y, Nakagomi O, Nakagomi T, Ueda S (1992) A VP4 sequence highly conserved in human rotavirus strain Au-1 and feline rotavirus strain FRV-1. J Gen Virol 73:1939-1946
14. Kalica AR, Flores J, Greenberg HB (1983) Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology 125: 194-205
15. Kaljot KT, Shaw RD, Rubin DH, Greenberg HB (1988) Infectious rotavirus enters cells by direct cell membrane pentration, not endocytosis. J Virol 62: 1136-1144
16. Kapikian AZ, Chanock RM (1990) Rotaviruses. In: Fields BN, Knipe DN, Melnick JL, Chanock CM, Roizman B, Shope RE (eds) Virology, vol 2. Raven Press, New York, pp 1353-1404
17. Katayama K, Oya A, Tanabayashi K, Okazaki K, Hishiyama M, Yamazaki S, Yamada A (1993) Differentiation of mumps vaccine strains from wild virus by single-strand conformation polymorphism of the P gene. Vaccine 11: 621-623
18. Kirkwood C, Masendycz PJ, Coulson BS (1993) Characterization and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotavirus. Virology 196: 79-88
19. Kobayashi N, Taniguchi K, Urasawa S (1990) Identification of operationally overlapping and independent cross-reactive neutralizations regions on human rotavirus VP4. J Gen Virol 71: 2615-2623
20. Larralde G, Flores J (1990) Identification of gene 4 alleles among human rotaviruses by polymerase chain reaction-derived probes. Virology 179: 469-473
21. Larralde G, Gorziglia M (1992) Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4. J Virol 66: 7438-7443
22. Larralde G, Li B, Kapikian AZ, Gorziglia M (1991) Serotype-specific epitopes(s) present on the VP8* subunit of rotavirus VP4 protein. J Virol 65: 3213-3218
23. Lazdins I, Coulson BS, Kirkwood C, Dyall-Smith M, Masendycz PJ, Sonza S, Holmes IH (1995) Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7. Virology 209: 80-89
24. Li B, Larralde G, Gorziglia M (1993) Human rotavirus K8 strain represents a new VP4 serotype. J Virol 65: 1658-1661
25. Mackow ER, Shaw RD, Matsui SM, Vo PT, Dang MN, Greenberg HB (1988) Characterization of the rhesus rotavirus VP3 gene: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci USA 85: 645-649
26. Offit PA, Blavat G, Greenberg HN, Clark HF (1986) Molecular basis for rotavirus virulence: role of gene segment 4. J Virol 57: 46-49
27. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770
28. Padilla-Noriega L, Dunn SJ, Lopez S, Greenberg HB, Arias CF (1995) Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human ST3. Virology 206: 148-154